2030 年までの南米および中米てんかん市場予測 - 地域分析 - タイプ別 (進行性ミオクロニーてんかん、反射性てんかん、全般てんかん、その他)、投与経路別 (経口、非経口、その他)、治療タイプ別 (第 1 世代の医薬品、第 2 世代の医薬品、第 3 世代の医薬品)、年齢層別 (成人および小児)、流通チャネル別 (病院薬局、小売薬局、その他)

BMIRE00030802 | Pages: 136 | Pharmaceuticals | Sep 2024 | Type: Regional | Status: Published
南米および中米のてんかん市場は、2022年に5億9,356万米ドルと評価され、2030年までに7億5,865万米ドルに達すると予想されています。また、2022年から2030年にかけて3.1%のCAGRを記録すると推定されています。

組織による啓発プログラムの急増が南米および中米のてんかん市場を活性化

てんかん、その症状、早期診断の重要性についての認識の高まりにより、医療を求める患者が急増しています。てんかん財団、てんかん協会、米国てんかん協会、セントラルフロリダてんかん協会などの組織は、この病気について人々を教育する上で重要な役割を果たしています。これらの組織の関与により、診断率が向上し、てんかん治療を必要とする患者層が拡大しました。世界中の組織が、この病気と利用可能な治療法に関する認識を広めるために、数多くの啓発キャンペーンを実施しています。ブラジルでは、ブラジルてんかん連盟(LBE)がてんかん啓発月間に全国的な啓発キャンペーンを実施しています。イベントを企画し、教育資料を配布し、メディアと連携しててんかんについての認識を高め、偏見を減らしています。このように、このような取り組みや啓発キャンペーンはてんかんの診断と治療の増加につながり、市場に有利な成長の機会を提供します。

南米および中米てんかん市場の概要

南米および中米のてんかん市場には、ブラジル、アルゼンチン、その他の南米および中米の国レベルの分析が含まれています。ブラジルは、この地域で大きな市場シェアを占めると予想されています。汎米保健機構によると、ラテンアメリカ、南米、カリブ海地域では治療ギャップがあり、50%を超えています。近年、各国はてんかんを含む非感染性疾患への重点を強化しています。 2023年に発表されたInternational Journal of Public Healthの記事によると、2019年に中南米諸国で合計1,375,066の障害調整生存年(DALY)がてんかんに起因しており、男性の罹患率が高いことが分かりました。

中南米てんかん市場の収益と2030年までの予測(百万米ドル)

中南米てんかん市場のセグメンテーション

中南米てんかん市場は、タイプ、投与経路、治療タイプ、年齢層、流通チャネル、国に分類されています。

タイプに基づいて、中南米てんかん市場は、進行性ミオクロニーてんかん、反射性てんかん、全般てんかん、その他に分類されています。全般性てんかんセグメントは、2022年に最大の市場シェアを占めました。

投与経路の観点から、中南米てんかん市場は、経口、非経口、その他に分類されます。経口セグメントは、2022年に最大の市場シェアを占めました。

治療タイプ別に、中南米てんかん市場は、第1世代の薬、第2世代の薬、第3世代の薬に分類されます。第3世代の薬セグメントは、2022年に最大の市場シェアを占めました。

年齢層に基づいて、中南米てんかん市場は、成人と子供に分かれています。成人セグメントは、2022年に大きな市場シェアを占めました。

流通チャネルの観点から、中南米てんかん市場は、病院薬局、小売薬局、その他に分類されます。病院薬局セグメントは、2022年に最大の市場シェアを占めました。

国別に見ると、南米および中米のてんかん市場は、ブラジル、アルゼンチン、その他の南米および中米に分かれています。ブラジルは、2022年に南米および中米のてんかん市場シェアを独占しました。

アボットラボラトリーズ、ファイザー社、エーザイ株式会社、UCB SA、リバノバ社、ノバルティスAG、メドトロニック社、GSK社、H.ルンドベック社は、南米および中米のてんかん市場で事業を展開している大手企業の一部です。

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Pipeline Studies for Epilepsy Therapy Approaches

4.1 Pipeline Studies for Epilepsy Therapy Approaches

4.1.1 Cell and Gene Therapy Approaches

4.1.2 Encapsulated cell bio delivery (ECB) system

4.1.3 Gene Therapy for Epilepsy Clinical Overview

4.1.3.1 Genetic Therapies Adopted for Clinic Research of Epilepsy

4.1.3.1.1 Gene Supplementation - Overview

4.1.3.1.2 Gene Modulation - Overview

4.1.3.1.3 Antisense Oligonucleotides and RNA Interference - Overview

4.1.3.1.4 Neuropeptides - Overview

4.1.3.1.5 Engineered Channels - Overview

4.1.3.1.6 Endogenous Channels - Overview

4.1.3.2 Pipeline Studies of Viral Vectors for Epilepsy

4.1.3.3 Pipeline Studies of Non-Viral Vectors for Epilepsy

4.1.3.3.1 Polymer-based Non-Viral Vectors for Epilepsy

4.1.3.3.2 Lipid-based Non-Viral Vectors for Epilepsy

4.1.3.4 Adeno-Associated Virus (AAV)-Mediated Neuromodulatory Peptides - Overview

4.1.3.5 Neurotrophic Factors for Gene Therapy Approaches

4.1.3.6 Potassium Channels for Human Epileptic Phenotypes

4.1.3.7 Enzyme Inducing Antiepileptic Drugs

5. South & Central America Epilepsy Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Epilepsy

5.1.2 Increasing Investments in Development of Epilepsy Therapies

5.2 Market Restraints

5.2.1 Recall of Products

5.3 Market Opportunities

5.3.1 Surge in Awareness Programs Conducted by Organizations

5.4 Future Trends

5.4.1 Gene Therapy as Promising Treatment Approach

5.5 Impact of Drivers and Restraints:

6. Epilepsy Market - South & Central America Analysis

6.1 South & Central America: Epilepsy Market

7. South & Central America Epilepsy Market Analysis - by Type

7.1 Overview

7.2 Progressive Myoclonic Epilepsy

7.2.1 Overview

7.2.2 Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Reflex Epilepsy

7.3.1 Overview

7.3.2 Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Generalized Epilepsy

7.4.1 Overview

7.4.2 Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Other

7.5.1 Overview

7.5.2 Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Epilepsy Market Analysis - by Route of Administration

8.1 Overview

8.2 Oral

8.2.1 Overview

8.2.2 Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Parenteral

8.3.1 Overview

8.3.2 Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Others

8.4.1 Overview

8.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Epilepsy Market Analysis - by Treatment Type

9.1 Overview

9.2 First Generation Drugs

9.2.1 Overview

9.2.2 First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Second Generation Drugs

9.3.1 Overview

9.3.2 Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Third Generation Drugs

9.4.1 Overview

9.4.2 Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Epilepsy Market Analysis - by Age Group

10.1 Overview

10.2 Adult

10.2.1 Overview

10.2.2 Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

10.3 Children

10.3.1 Overview

10.3.2 Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Epilepsy Market Analysis - by Distribution Channel

11.1 Overview

11.2 Hospital Pharmacies

11.2.1 Overview

11.2.2 Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

11.3 Retail Pharmacies

11.3.1 Overview

11.3.2 Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

11.4 Others

11.4.1 Overview

11.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

12. South & Central America Epilepsy Market - Country Analysis

12.1 South & Central America Epilepsy Market Overview

12.1.1 South & Central America: Epilepsy Market Breakdown, by Key Country, 2022 and 2030 (%)

12.1.1.1 Brazil: Epilepsy Market Overview

12.1.1.2 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.2.1 Brazil: Epilepsy Market Breakdown, by Type

12.1.1.2.2 Brazil: Epilepsy Market Breakdown, by Route of Administration

12.1.1.2.3 Brazil: Epilepsy Market Breakdown, by Treatment Type

12.1.1.2.4 Brazil: Epilepsy Market Breakdown, by Age Group

12.1.1.2.5 Brazil: Epilepsy Market Breakdown, by Distribution Channel

12.1.1.3 Argentina: Epilepsy Market Overview

12.1.1.4 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.4.1 Argentina: Epilepsy Market Breakdown, by Type

12.1.1.4.2 Argentina: Epilepsy Market Breakdown, by Route of Administration

12.1.1.4.3 Argentina: Epilepsy Market Breakdown, by Treatment Type

12.1.1.4.4 Argentina: Epilepsy Market Breakdown, by Age Group

12.1.1.4.5 Argentina: Epilepsy Market Breakdown, by Distribution Channel

12.1.1.5 Rest of South & Central America: Epilepsy Market Overview

12.1.1.6 Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

12.1.1.6.1 Rest of South & Central America: Epilepsy Market Breakdown, by Type

12.1.1.6.2 Rest of South & Central America: Epilepsy Market Breakdown, by Route of Administration

12.1.1.6.3 Rest of South & Central America: Epilepsy Market Breakdown, by Treatment Type

12.1.1.6.4 Rest of South & Central America: Epilepsy Market Breakdown, by Age Group

12.1.1.6.5 Rest of South & Central America: Epilepsy Market Breakdown, by Distribution Channel

13. Industry Landscape

13.1 Overview

13.2 Growth Strategies in Epilepsy Market

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Pfizer Inc

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Eisai Co Ltd

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 UCB SA

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 LivaNova Plc

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Novartis AG

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Medtronic Plc

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 GSK Plc

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 H. Lundbeck AS

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners

 

 

 

List of Tables

Table 1. South & Central America Epilepsy Market Segmentation

Table 2. Cell Therapy Approach - An Overview

Table 3. Gene Therapy Approach - An Overview

Table 4. Encapsulated cell bio delivery (ECB) system Cell and Gene Therapy Approach - An Overview

Table 5. Preclinically Tested Genetic Therapies for Epilepsy

Table 6. Clinical Trials for Epilepsy Gene Therapy: Overview

Table 7. Viral Vectors Comparison with respect to Various Parameters

Table 8. Subfamilies of Human K+ Channels Involved in Epilepsies

Table 9. Enzyme-Inducing Antiepileptic Drugs

Table 10. Enzyme-Inducing Antiepileptic Drugs & Drug Target Types Overview

Table 11. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 12. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 13. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type

Table 14. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group

Table 15. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 16. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 17. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 18. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type

Table 19. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group

Table 20. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 21. Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 22. Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration

Table 23. Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type

Table 24. Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group

Table 25. Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel

Table 26. Recent Organic Growth Strategies in Epilepsy Market

Table 27. Recent Inorganic Growth Strategies in the Epilepsy Market

?

List of Figures

Figure 1. South & Central America Epilepsy Market Segmentation, by Country

Figure 2. Epilepsy Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Epilepsy Market Revenue (US$ Million), 2020-2030

Figure 5. Epilepsy Market Share (%) - by Type (2022 and 2030)

Figure 6. Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Epilepsy Market Share (%) - by Route of Administration (2022 and 2030)

Figure 11. Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Epilepsy Market Share (%) - by Treatment Type (2022 and 2030)

Figure 15. First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Epilepsy Market Share (%) - by Age Group (2022 and 2030)

Figure 19. Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Epilepsy Market Share (%) - by Distribution Channel (2022 and 2030)

Figure 22. Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. South & Central America: Epilepsy Market, By Key Country - Revenue (2022) (US$ Million)

Figure 26. South & Central America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 27. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Growth Strategies in Epilepsy Market

 

 

?

  1. Abbott Laboratories
  2. Pfizer Inc
  3. Eisai Co Ltd
  4. UCB SA
  5. LivaNova Plc
  6. Novartis AG
  7. Medtronic Plc
  8. GSK Plc
  9. H. Lundbeck AS
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America epilepsy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America epilepsy market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America epilepsy market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440